Industry News

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced its participation at the recent Congress of Neurological Surgeons Annual Meeting in San Diego, CA, which took place on September 24-28, 2016.."/>
Misonix Features BoneScalpel™ and SonaStar™ Systems at Congress of Neurological Surgeons ("CNS")
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today that ReGenTree, RegeneRx's U.S. joint venture with GtreeBNT, initiated its second Phase 3 trial for Dry Eye Syndrome this month and will begin patient enrollment shortly. The double-masked, placebo-controlled trial is expected to enroll approximately 500 patients who will be treated for..."/>
RegeneRx Joint Venture Initiates Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome
LivaNova PLC, a market-leading medical technology company, announced today its participation in the 30th European Association for Cardio-Thoracic Surgery Annual Meeting, October 1- 5, 2016, in Barcelona, Spain. At its exhibit and Tecnosuite in the CCBI Conference Center, LivaNova will celebrate several major patient treatment milestones for its Cardiac Surgery Business Unit and discuss the Company's campaign to "Cut Through Complexity" using..."/>
LivaNova PLC Announces Participation in 30th EACTS Annual Meeting
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, will visit the Nasdaq MarketSite in Times Square, to kick off Breast Cancer Awareness Month for the 11 th consecutive year. In honor of the occasion, Steve MacMillan, Chairman, President and Chief Executive Officer and spokeswoman Sheryl Crow, will ring the Opening Bell. Where: Nasdaq MarketSite– 4 Times Square– 43 rd& Broadway– Broadcast..."/>
Breast Cancer Survivor and Grammy Award-Winner Sheryl Crow and Hologic, Inc. (Nasdaq: HOLX) to Ring The Nasdaq Stock Market Opening Bell
LivaNova PLC, a market-leading medical technology company, announced today its participation in the 30 th European Association for Cardio-Thoracic Surgery Annual Meeting, October 1– 5, 2016, in Barcelona, Spain.. At its exhibit and Tecnosuite in the CCBI Conference Center, LivaNova will celebrate several major patient treatment milestones for its Cardiac Surgery Business Unit and discuss the Company’ s campaign to“ Cut Through Complexity” using..."/>
LivaNova PLC Announces Participation in 30th EACTS Annual Meeting
Cipla Ltd on Friday informed stock exchanges that said it got four observations from US Food and Drug Administration for three of its manufacturing facilities in Goa. "US FDA recently concluded audit of our three manufacturing facilities at Goa and has issued four observations across these three facilities," the company said. The company didn't specify the nature of the observations."/>
Cipla gets 4 observations from US FDA for its three plants in Goa [Mint, New Delhi]
Mylan Launches Generic Fortamet® Tablets
Det norske oljeselskap ASA: Primary Insider Notice
Emergent BioSolutions Inc. today provided an update on the status of its 2011 BioThrax ® procurement contract and the status of its discussions with the Centers for Disease Control and Prevention for a follow-on procurement contract for BioThrax.. 2011 Procurement Contract CDC has exercised an option to procure all remaining BioThrax doses, thereby committing to take delivery of the full 44.75 million doses, under the procurement contract..."/>
Emergent BioSolutions Provides Update on Status of BioThrax Procurement Contract and Discussions With CDC
Chartwell Retirement Residences will issue its financial results for the three and nine months ended September 30, 2016 on the afternoon of November 9, 2016.. A conference call hosted by Brent Binions, President and Chief Executive Officer, Vlad Volodarski, Chief Financial Officer and Chief Investment Officer and Karen Sullivan, Chief Operating Officer will be held Friday, November 10, 2016 at 10:00 AM ET. The telephone numbers for the conference..."/>
Chartwell Third Quarter 2016 Results and Conference Call
SunLink Health Systems, Inc. today announced a loss from continuing operations for its fourth fiscal quarter ended June 30, 2016 of $823,000 or a loss of $0.09 per fully diluted share, compared to a loss from continuing operations of $7,000 or a loss of $0.00 per fully diluted share, for the quarter ended June 30, 2015. Net loss for the quarter ended June 30, 2016 was $1,234,000, or a loss of $0.13 per fully diluted share, compared to net earnings of $92,000, or $0.01 per fully..."/>
SunLink Health Systems, Inc. Announces Fiscal 2016 Fourth Quarter and Full-Year Results
Delcath Systems, Inc., an interventional oncology company focused on treatments for primary and metastatic liver cancers, today announced the pricing of an underwritten public offering of 425,000 shares of its common stock at a price of $3.00 per share, for gross proceeds of $1,275,000. Investors will also receive 0.35 warrants to purchase an additional share of common stock at an initial exercise price of $3.00 per share, with a term of five years."/>
Delcath Prices Underwritten Public Offering of Common Stock and Warrants
MicroVision, Inc., a leader in innovative ultra-miniature projection display and sensing technology, today announced that Colonel Yalon Farhi has joined its board of directors. Colonel Farhi’ s election expands the number of MicroVision board members to eight. Colonel Farhi’ s career encompasses a wealth of experience that spans serving in the Israeli Defense Forces, lecturing at Bnei David Institute since 1998, working for an Israeli non-government..."/>
Colonel Yalon Farhi Joins MicroVision’s Board of Directors
Cerner, a global leader in health care technology. Through its Business Office Services offering, Cerner will manage professional revenue cycle management across the health system’ s 200- member employed physician group practice.. In conjunction with the existing systemwide Cerner Millennium ®..."/>
Miami Children’s Health System Expands Relationship With Cerner
Rosetta Genomics disclosed on Thursday the execution of an exclusive distribution agreement for the sales and marketing of RosettaGX Reveal in Israel. The distribution agreement was signed with Rhenium Ltd, one of Israel's leading suppliers of laboratory, research and diagnostic equipment. According to Rosetta Genomics, RosettaGX Reveal, its first-of-its-kind microRNA classifier for indeterminate thyroid nodules, is a Thyroid microRNA..."/>
Rosetta Genomics signs RosettaGX Reveal distribution agreement in Israel
Emergent BioSolutions Inc. announced today that it has signed a multi-year contract with the Biomedical Advanced Research and Development Authority, which is a division of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response, for the advanced development and delivery of NuThrax TM, also known as AV7909, the company’ s next generation anthrax vaccine candidate. The contract, valued at up..."/>
Emergent BioSolutions Awarded BARDA Contract for Advanced Development and Delivery of NuThrax, a Next Generation Anthrax Vaccine, Valued at Up to $1.6 Billion
Kindred Biosciences, Inc., a biopharmaceutical company focused on saving and improving the lives of pets, today announced the submission to FDA of the Safety technical section of the New Animal Drug Application for Mirataz™. This is the final major technical section to be submitted for Mirataz. The Chemistry, Manufacturing, and Controls technical section was submitted in May 2016 and the Effectiveness technical section was submitted in..."/>
Kindred Biosciences Submits Final Major New Animal Drug Application Technical Section for Safety for Mirataz to FDA and Launches KindredBio Equine Website
CohBar, Inc., an innovative biotechnology company focused on developing mitochondria based therapeutics for age-related diseases, today announced the selection of two analogs from the company’ s MOTS-c program for advancement into IND-enabling activities. The drug candidates, CB4209 and CB4211, have demonstrated significant therapeutic potential in pre-clinical models for the treatment of obesity, with additional confirmatory studies planned to..."/>
CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities
Kite Pharma Inc., Ariad Pharmaceuticals, Inc., Puma Biotechnology Inc., Juno Therapeutics Inc..."/>
Biotechs and the Advancements in Cancer Oriented Clinical Trials
Community Health Systems said on Thursday that its subsidiaries have entered into a definitive agreement for the sale of four hospitals as well as their associated assets to subsidiaries of Curae Health Inc.. The deal includes the 95- bed Merit Health Gilmore Memorial in Amory, Mississippi; 112- bed Merit Health Batesville in Batesville, Mississippi; 181- bed Merit Health Northwest Mississippi in Clarksdale, Mississippi; and 126- bed Highlands Regional..."/>
Community Health Systems agrees sale of four rural hospitals
Vermillion company, reported on Thursday the signing of a major contract agreement for its US FDA cleared ovarian cancer risk assessment test, OVA1, with CareFirst BlueCross BlueShield. CareFirst reportedly serves over three million patients throughout Maryland and Washington DC and Virginia and the area has the greatest population density in the US. ASPiRA LABs' OVA1 is a proprietary US FDA-cleared blood test designed to help physicians assess the risk of..."/>
ASPiRA LABs signs OVA1 contract agreement with CareFirst BlueCross BlueShield

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology721 Articles
Consumer Discretionary629 Articles
Financials483 Articles
Industrials418 Articles
Health Care410 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at